In Vitro Fertilization Market: Fertility Trends, Assisted Reproduction & Growth Outlook

According to IMARC Group's latest research publication, The global in vitro fertilization market size was valued at USD 28.1 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 51.3 Billion by 2034, exhibiting a CAGR of 6.90% during 2026-2034.

How AI is Reshaping the Future of In Vitro Fertilization Market

• AI-Powered Demand Forecasting and Patient Management: AI-driven systems analyze patient data, treatment histories, and clinical success rates to optimize IVF cycles and improve patient outcomes. Clinics adopting AI-based forecasting tools are enhancing scheduling efficiency, reducing treatment delays, and improving overall success rates.
• AI-Driven Embryo Selection and Personalized Treatment: Artificial intelligence is revolutionizing embryo selection through advanced imaging and predictive analytics. Machine learning algorithms assess embryo quality, genetic viability, and implantation potential, enabling clinicians to select the most promising embryos and increase pregnancy success rates.
• Smart Laboratory Monitoring and Quality Control Systems: AI-powered monitoring systems enable real-time tracking of laboratory conditions such as temperature, humidity, and culture environments. These systems detect anomalies in embryo development and lab processes, ensuring consistency, reducing human error, and improving treatment reliability.

Stay Informed with the Latest 2026 Market Updates

In Vitro Fertilization Industry Overview:

The in vitro fertilization sector is experiencing strong growth driven by rising infertility rates, delayed parenthood trends, and continuous advancements in assisted reproductive technologies. Europe dominates with 37.6% market share, supported by favorable regulatory frameworks, advanced healthcare infrastructure, and high awareness regarding fertility treatments. The market is further strengthened by increasing accessibility to fertility services and expanding networks of specialized clinics.

In Vitro Fertilization Market Trends & Drivers

The increasing prevalence of infertility worldwide represents the primary driver of the market, influenced by lifestyle changes, stress, and health conditions. Growing awareness and acceptance of assisted reproductive technologies are encouraging more couples to opt for IVF treatments.

The rising trend of delayed parenthood, particularly in developed economies, is significantly boosting demand for fertility treatments. Changing social dynamics and career priorities are leading individuals to seek advanced reproductive solutions later in life.

Technological advancements in reproductive medicine, including embryo freezing, genetic screening, and improved laboratory techniques, are enhancing success rates and expanding treatment options. These innovations are making IVF more efficient, reliable, and widely adopted globally.

Leading Companies Operating in the Global In Vitro Fertilization Industry:

• Vitrolife AB
• CooperSurgical Inc.
• Thermo Fisher Scientific Inc.
• Cook Medical
• Genea Biomedx
• Esco Micro Pte Ltd
• Merck KGaA
• Ferring Pharmaceuticals
• FUJIFILM Irvine Scientific
• Kitazato Corporation

In Vitro Fertilization Market Report Segmentation:

By Product:

• Reagents and Media
• Instruments
• Accessories

Reagents and media represent the largest segment, driven by their essential role in embryo culture, preservation, and overall IVF procedures.

By Procedure Type:

• Fresh Embryo IVF
• Frozen Embryo IVF
• Donor Egg IVF
• By Cycle Type:
• Conventional IVF
• Intracytoplasmic Sperm Injection (ICSI)

ICSI represents the largest segment, driven by its higher success rates in cases of male infertility and increasing adoption in advanced fertility treatments.

By End User:

• Fertility Clinics
• Hospitals
• Clinical Research Institutes

Fertility clinics represent the largest segment, supported by specialized infrastructure, advanced technologies, and increasing patient preference for dedicated fertility care centers.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Europe exhibits clear dominance in the in vitro fertilization market with 37.6% market share, driven by strong healthcare infrastructure, supportive regulations, and increasing adoption of advanced reproductive technologies.

Recent News and Developments in In Vitro Fertilization Market

• January 2024: Vitrolife announced advancements in embryo culture media and time-lapse imaging technologies to improve IVF success rates.
• March 2024: CooperSurgical expanded its fertility solutions portfolio through strategic acquisitions aimed at enhancing reproductive healthcare services.
• June 2024: Thermo Fisher Scientific introduced advanced laboratory solutions to support IVF clinics with improved precision and efficiency.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.